Cargando…
Optimizing Trial Designs for Targeted Therapies
An important objective in the development of targeted therapies is to identify the populations where the treatment under consideration has positive benefit risk balance. We consider pivotal clinical trials, where the efficacy of a treatment is tested in an overall population and/or in a pre-specifie...
Autores principales: | Ondra, Thomas, Jobjörnsson, Sebastian, Beckman, Robert A., Burman, Carl-Fredrik, König, Franz, Stallard, Nigel, Posch, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042421/ https://www.ncbi.nlm.nih.gov/pubmed/27684573 http://dx.doi.org/10.1371/journal.pone.0163726 |
Ejemplares similares
-
Optimized adaptive enrichment designs
por: Ondra, Thomas, et al.
Publicado: (2017) -
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review
por: Ondra, Thomas, et al.
Publicado: (2016) -
Estimands and Complex Innovative Designs
por: Collignon, Olivier, et al.
Publicado: (2022) -
Determination of the optimal sample size for a clinical trial accounting for the population size
por: Stallard, Nigel, et al.
Publicado: (2016) -
Decision-theoretic designs for small trials and pilot studies: A review
por: Hee, Siew Wan, et al.
Publicado: (2015)